SB 2122025 to 2026
bill
2025 to 2026 Regular Session · State Senate bill
SB 212
Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.
In committee Last action April 10, 2026: Died in Committee
Official bill page and text: kslegislature.gov
Sponsors 1
- Prime sponsor
- Dinah Sykes
Status
In committee as of April 10, 2026. The 2026 session has adjourned; the 2027 session convenes January 11, 2027.
Referred to: Senate Financial Institutions and Insurance (from the official referral record)
Roll-call votes 0
No roll-call votes recorded for this measure.
Timeline 3
| Date | Chamber | Action |
|---|---|---|
| April 10, 2026 | Senate | Died in Committee |
| February 6, 2025 | Senate | Referred to Senate Committee on Financial Institutions and Insurance |
| February 5, 2025 | Senate | Introduced |
Data: Open States (API v3; public data, attribution appreciated). Official record: kslegislature.gov. Bill pages link to the official text, not copied.